Add BrightSurf on Google Email

Lifesaving drug for severe bleeding after childbirth could be made accessible for all, study suggests

Researchers from the London School of Hygiene & Tropical Medicine found that intramuscular administration of tranexamic acid (TXA) is safe and quickly reaches therapeutic concentrations in pregnant women. Oral TXA was also well-tolerated but took an hour to reach therapeutic blood concentrations.

SourceLondon School of Hygiene & Tropical Medicine·JournalBritish Journal of Obstetrics and Gynaecology·TypeRandomized controlled/clinical trial·DateApr 5, 2023

Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy

In a phase III trial, elacestrant showed significant benefits in decreasing death or disease progression and increasing progression-free survival compared to standard of care. The treatment was well-tolerated with manageable side effects, offering hope for patients with ER-positive/HER2-negative metastatic breast cancer.

Tattooing improves response to DNA vaccine

Researchers have found that tattooing is a more effective way of delivering DNA vaccines than intramuscular injection, producing stronger humoral and cellular immune responses. This method could have a role in routine vaccination of cattle or delivering therapeutic vaccines to humans.

SourceBMC (BioMed Central)·JournalGenetic Vaccines and Therapy·DateFeb 6, 2008